Previous Close | 2.2500 |
Open | 2.2500 |
Bid | 2.3600 x 0 |
Ask | 2.4100 x 0 |
Day's Range | 2.1800 - 2.4200 |
52 Week Range | 2.1500 - 7.5000 |
Volume | |
Avg. Volume | 70,946 |
Market Cap | 238.195M |
Beta (5Y Monthly) | 0.95 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0870 |
Earnings Date | Nov 29, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 3.50 |
GUELPH, ON /ACCESSWIRE / June 6, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce that on March 28, 2022, the Canadian national phase was initiated for its patent application directed to its ZenGUARD™ technology.
GUELPH, ON / ACCESSWIRE / June 1, 2022 / Zentek Ltd. ("Zentek" or the "Company" or the "Corporation") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, has retained Halteres Associates ("Halteres"), a leading consultancy focused on global health, diagnostics, and point-of-care testing, to help with commercialization of the aptamer-based rapid detection technology exclusively licensed by Zentek pursuant to its licence agreement dated April 11, 2021 with
GUELPH, ON / ACCESSWIRE / May 26, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, is pleased to announce the grand opening of its industrial scale ZenGUARD™ antimicrobial production facility in Guelph, Ontario on Friday June 17th, 2022, at 2:00 pm.